Login

Financial Snapshot

Revenue
TTM
$646.3M
Gross Margin
TTM
80.27%
Net Income
TTM
-$511.3M
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
130.3%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
Book Value
2026 Q1
$311.6M
Cash
2026 Q1
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
$204.2M

Stock Price

Loading...
Market Cap: $3.1963 Billion

About Hinge Health Inc

Hinge Health Inc (NYSE: HNGE) is a digital musculoskeletal health company that delivers AI-supported care for joint and muscle conditions to employer and health plan members. Revenue comes from member subscription fees paid by clients, recognized ratably over a 12-month subscription period once a billable activity is completed. Clients are primarily employers, health plans, and government entities that contract Hinge Health as the sole digital MSK care provider for their eligible lives, typically under three-year agreements. As of December 31, 2025, the company served 2,830 clients, 782,890 members, and 20,105 thousand LTM average eligible lives, with LTM calculated billings of $671.4 million. The platform covers acute injury, chronic pain, and post-surgical rehabilitation, and includes AI-powered motion tracking, a proprietary FDA-cleared electrical nerve stimulation wearable device called Enso, and an AI-assisted care team of licensed physical therapists, physicians, and board-certified health coaches. From inception through December 31, 2025, a majority of clients were contracted through Hinge Health's partner network of health plans, PBMs, and TPAs.

Revenue model
Member subscription fees paid by clients (employers, health plans, government entities) to provide eligible employees or members access to the platform. Revenue is recognized ratably over the 12-month member subscription period beginning when a billable activity is completed. Partners receive administrative or marketing fees when clients contract through them.
Products and services
Digital MSK care platform covering acute injury, chronic pain, and post-surgical rehabilitation. Key components include AI-powered motion tracking technology, the Enso proprietary wearable electrical nerve stimulation device (FDA-cleared, supported by 8 issued U.S. and European patents and 12 pending patent applications as of December 31, 2025), a generative AI Care Team Assistant for care team workflow automation, and a care team of licensed physical therapists, physicians, and Nationally Board-Certified Health and Wellness Coaches.
Customers and end markets
Employers (including self-funded benefit plan sponsors), health plans, and government entities that purchase or administer healthcare benefits. End beneficiaries are employees and plan members who enroll as contracted lives. Demand is driven by client need to manage MSK-related healthcare costs. As of December 31, 2025, the company had 2,830 clients.
Value-chain role
Direct-to-employer and health plan digital care platform sitting between payers or self-insured employers and members. Sells through a direct sales force and a partner network of health plans, PBMs, TPAs, centers of excellence, and healthcare navigation partners. Partners facilitate contracting, implementation, and billing, particularly for smaller clients. Implementations typically complete within 40 to 100 days of contract signing.

Source: SEC 10-K, filed 2026-03-03

Industry: Services-Computer Processing & Data Preparation

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support